Yes. Biocryst Pharmaceuticals filed a WARN notice in the last 12 months covering 47 jobs. The most recent was filed Aug 4, 2026 for Hoover, Alabama.
47 roles affected across 1 filing.
🟠
Canary status: CallingEVIDENCE-BASED · NOT A PREDICTION
1 WARN filing in the last 4 months (47 jobs) · 1 SEC restructuring disclosure (8-K Item 2.05) · heavy executive turnover (3 SEC leadership-change filings) · M&A activity (SEC 8-K Item 2.01)
CanaryWhistle's own assessment, computed from the public filings listed on this page. It is a read of hiring and workforce activity, not a statement about Biocryst Pharmaceuticals's solvency or creditworthiness. Not a credit rating and not financial advice. See our sources and method.
ClinicalCustomer Support
Corporate signalsSEC · PBGC · PRIMARY SOURCES
Material corporate events on record for Biocryst Pharmaceuticals, beyond the WARN notice, that fill in the wider story of a company under pressure. Each links to its official source. No other layoff tracker connects these.
Jun 29, 2026RestructuringSEC Form 8-K, Item 2.05, filed 2026-06-29 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jun 12, 2026Executive ChangeSEC Form 8-K, Item 5.02, filed 2026-06-12 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jan 23, 2026AcquisitionSEC Form 8-K, Item 2.01, filed 2026-01-23 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Dec 11, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-12-11 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Oct 14, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-10-14 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Aug 11, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-08-11 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jul 31, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-07-31 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jul 7, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-07-07 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jun 16, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-06-16 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Jun 4, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-06-04 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
May 1, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-05-01 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →
Apr 10, 2025Executive ChangeSEC Form 8-K, Item 5.02, filed 2025-04-10 by BIOCRYST PHARMACEUTICALS INC (BCRX).SEC filing →